Immobilized LILRB1/CD85j/ILT2 hFc Chimera, Human, hFc Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Anti-LILRB1 Antibody, hFc Tag with the EC50 of 15.0ng/ml determined by ELISA.
The purity of LILRB1/CD85j/ILT2 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.
LILRB1/CD85j/ILT2 hFc Chimera, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.
LILRB1/CD85j/ILT2 hFc Chimera, Human, hFc Tag captured on Protein A Chip can bind Human HLA-G Tetramer, His Tag with an affinity constant of 1.49nM as determined in SPR assay (Biacore T200).
LILRB1/CD85j/ILT2 hFc Chimera, Human
LILRB1, also known as CD85j and ILT2, is a 110 kDa transmembrane glycoprotein in the LILR immunoregulatory protein family. Mature human LILRB1 consists of a 438 amino acid (aa) extracellular domain (ECD) with 4 tandem Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 4 inhibitory ITIM motifs.LILRB1 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. Receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response.
| Z05594 | |
|
|
|
| ¥46,636.00 | |
|
|
|
|
|
|
| Ask us a question | |
